Osamu Fujishita
Kyushu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Osamu Fujishita.
Journal of the Nippon Hospital Pharmacists Association | 1996
Kyoko Kuroda; Osamu Fujishita; Kazuya Kotsubo; Yasushi Nakao; Ryozo Oishi
Sterilized chlorhexidine gluconate solutions (GCH) in 500 ml polypropylene containes are prepared in our hospital pharmacy. To determine the expiration period after unsealing the container, the stability and potency of 0.02% GCH were examined by high-performance liquid chromatography and cultivation tests, respectively. The main ingredient of 0.02% GCH which had been used partially for more than 6 months, was maintained at over 95% of its initial concentration at room temperature. No bacterium nor fungus was evident in the 0.02% GCH partially used at several sections for 2-15 months, when examined by three different cultivation tests. Under the conditions of excess microbe contamination such as falling microbial test and sticking fingers test, 0.02% GCH prevented the growth of microbes. These results suggest that there is only a minor possibility of microbial contamination in the sterilized 0.02% GCH after the container has been unsealed.In general, this preparation may be usable for at least one month after unsealing although the existence of microbes resistant to GCH has been reported.
Japanese Journal of Hospital Pharmacy | 1995
Ayako Hisazumi; Osamu Fujishita; Kenji Otsubo; Ryozo Oishi
Small volume injections (SVIs) of NaHCO3 and heparin used in the United States have been reported to contain 60-70% of the maximum allowable number of particles described in United States Pharmacopeia (USP). We evaluated SVIs of KC1, CaCl2, NaHCO3 and heparin used in Japan using the electronic liquid-borne particle system. All SVIs examined showed remarkably lower numbers of particles than the limits described in USP. Even if several injections of each preparations are used together, the particle number may not exceed the USP limits.
Chemical & Pharmaceutical Bulletin | 1983
Osamu Fujishita; Shun Higuchi; Manabu Yoshikawa; Toshinobu Aoyama; Masayoshi Horioka
Pda Journal of Pharmaceutical Science and Technology | 1995
Osamu Fujishita; Toshiaki Sendo; Ayako Hisazumi; Kenji Otsubo; Toshinobu Aoyama; Ryozo Oishi
Journal of the Nippon Hospital Pharmacists Association | 1996
Osamu Fujishita; Kyoko Kuroda; Yasushi Nakao; Yoshihiro Natori; Masashi Fukui; Ryozo Oishi
Chemical & Pharmaceutical Bulletin | 1988
Osamu Fujishita; Masaaki Hirakawa; Kazuhiro Nakashima; Shun Higuchi; Kenji Otsubo; Toshinobu Aoyama; Hironobu Karasawa
Chemical & Pharmaceutical Bulletin | 1986
Osamu Fujishita; Ryuichi Fukuoka; Masaaki Hirakawa; Shun Higuchi; Toshinobu Aoyama; Masayoshi Horioka
Hukuoka acta medica | 1995
Kotsubo K; Osamu Fujishita; Nonaka N; Sonoda M; Yasushi Nakao; Ryozo Oishi
Chemical & Pharmaceutical Bulletin | 1990
Osamu Fujishita; Kazuhiro Nakashima; Masaaki Hirakawa; Kenji Otsubo; Shun Higuchi; Toshinobu Aoyama
Chemical & Pharmaceutical Bulletin | 1980
Katsumi Takata; Osamu Fujishita; Hiromasa Kameya; Toshinori Tsuruta; Masanori Uehara